Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RFMD Announces Retirement of Co-Founder Jerry D. Neal From the Company:
http://finance.yahoo.com/news/rfmd-announces-retirement-co-founder-200000963.html
over 100,000 traded after hours in the $11.85 range.
This could move the pps up a little.... I hope:
A Classic Biotech Long Shot
By Sham Gad04/05/12 - 09:02 AM EDT
TheStreet Premium Services
A complimentary preview
of Real Money
NEW YORK (Real Money -- Columbia Laboratories(CBRX) is your classic long-shot pharmaceutical play. In this particular case, the outcome is completely binary: heads you win big, tails you can lose 50% based on the outcome of one event.
<a href='http://addelivery.thestreet.com/ck.php?n=a99d679d&cb=INSERT_RANDOM_NUMBER_HERE' target='_blank'><img src='http://addelivery.thestreet.com/avw.php?zoneid=387&cb=INSERT_RANDOM_NUMBER_HERE&n=a99d679d' border='0' alt='' /></a>
Columbia is a $63 million business that engages in the development and commercialization of women's health care products. The company's products are aimed at providing solutions for infertility, pregnancy support, and other gynecological conditions. Earlier this year, shares traded above $3. Today they fetch $0.70 due to an unfavorable decision from the Food and Drug Administration. If that issue can be resolved, shares could possibly double or triple.
Columbia still derives sales and royalty revenues from its progesterone gel Crinone, which is marketed by Watson Pharmaceuticals(WPI) in the U.S. and internationally by a division of Merck(MRK). Net revenues from Merck for international sales of Crinone grew 41% in 2011 from 2010 and were up slightly for Watson over the same period. So that product still holds value for Columbia.
What sank the shares, however, was a decision by the FDA back in January 2012 stating that Columbia's new drug application for Prochieve did not prove to be effective compared to placebo in reducing the risk of preterm births. That news sent shares plummeting by 54% -- no surprise in the pharmaceutical industry, where companies live and die by FDA decisions. Over the next several days, shares declined another 55%, leaving the company trading at where it is today.
But Columbia has taken several steps that, if successful, could lead to a triple-digit percentage gain in the shares. If not, the downside risk appears to be mitigated by a cash rich balance sheet, along with the residual value from Crinone royalties.
First, Columbia has transferred the new drug application for Prochieve to its partner, Watson Pharmaceuticals. Watson now has full rights and regulatory responsibilities for all activities relating to this new drug application. Watson intends to address the FDA's concerns, and if it can prove successful, Columbia has significant upside potential.
Second, Columbia has retained the services of investment bank Cowen and Co. to examine strategic alternatives. In conjunction with this move, Columbia has scaled down the size of its workforce by 42% in order to preserve cash. Currently, Columbia sits on $25 million in cash against a market cap of $69 million and no debt. That, along with revenue from its existing products and a Nasdaq listing, puts a floor on the downside if the company were forced to liquidate or be taken over. That downside scenario compares with the upside potential if Watson, an $8 billion company, can prove successful with the FDA with respect to the new drug application.
They're doing a good job... soon we'll be in the negative before the open.
"Administrative Expense Requests" - I received a legal form relative to the Bankruptcy Court proceedings making reference to Administrative Expense claims and Request. What expense requests are they refering to and is any action required? Thanks for any info.
Hey Sergey.... I keep looking at these charts and try to make sense out of them, but I justcan't. What does this chart show us?
What symbols are you using...? I have WMIH and show no activity at all.
You could be right... looks like it may open around .755. Let's hope it flys.
I hope I'm wrong, but I think you need a new compass.
I think it's about to break out!!!
She's moving now.
Looks like a move is in progress.... could this be it?
This news isn't bad.... lets see how the market reacts tomorrow:
SHANGHAI, China, March 20, 2012 (GLOBE NEWSWIRE) -- RF Micro Devices, Inc. (Nasdaq:RFMD), a global
leader in the design and manufacture of high-performance radio frequency components and compound
semiconductor technologies, today announced it has shipped over one billion cellular power
amplifiers (PAs) to handset manufacturers headquartered in the Greater China area. This
significant industry milestone demonstrates RFMD's ongoing commitment to providing China-based
customers with operational scale, technological innovation and an industry-leading cost structure.
Considering it was a down day we came out pretty good.
That says it all.
Hey Jen... is it time to look at the charts yet?
It certainly seems to have bottomed out and looking like it's going to mimic the rise it made in February when it hit the mid 5's. It would be nice if it went back to match last November's numbers. But that's just how it "looks" to me... I believe the charts are a little more scientific.
Hi Eastunder... What do the charts say today? Thanks
What the hell is going on with this stock...? Does it ever stop falling?
My error - not trading at $.06 - different stock popped into my screen. Sorry!!!
Trading at $.06 after hours. Hope it's just panic selling and it pops up to something reasonable in the morning.
Holy Crap... work force reduction from 24 down to 14 - does not bode well for us.
Is this stock being controlled by the MM's? It's pattern seems so irratic and every effort to move forward seems to be held back.
Perhaps... 1,000 shares @ $.70 pre-market at 8:54AM. We can only hope. With the FDA behind us I expect things to return to normal and the true value to return.
Can't find any news to account for this nice move up - anyone see anything that I might have missed?
Look a little closer... if the pension plan if fully funded by 2015.
What is interesting is that the advisory boards vote was not unanimous - four members did not vote against it. That seems a little on the plus side.
I guess I've visited the site on numerous occasions and each time the same last message was displayed so I finally decided to comment - I'm more a reader for the latest news and updates than I am a writer.
Doesn't anybody post here anymore?
42,700 SHARES AT $0.83 - IS IT ABOUT TO MOVE?
What's Columbia Lab's position on the claim of mis-information?
How do you know when your stocks have been "locked"?
Thanks WithCatz, I've read it and think I understand it, but have not received my package yet so am still a little in the dark. I think I just need to leave the box "blank" and vote "Yes" to get the most benefit... am I right?
Are we dead in the water or is there still some value here?
Is it too late to get on the list and how do you do it?
But still no boat.
Lots of ors (oars), but no boat!!!
Anybody following this company? Looks like they are into some good stuff, but today the stock really tanked an no new - anybody know what's happening?
Thanks,
Daddy Dog
It's been years since I posted on this site or at least I think it was this site, back before the split - I still have my worthless shares which I paid quite a bit more for back then. In fact you were not allowed to say anything against the company which was supposidly going to do great things.... well I guess we were, or at least I was, led down the garden path.
What is new....? do they still own Sanswire? An update would be appreciated.
Thanks,
Daddy Dog